MR
Publicaties op Oncologisch.com
Pembrolizumab plus enzalutamide versus placebo plus enzalutamide for chemotherapy-naive metastatic castration-resista...
Pembrolizumab plus enzalutamide and androgen deprivation therapy versus placebo plus enzalutamide and androgen depriv...
Prospective gerandomiseerde phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal ce...